Kaplan v. First Hartford Corp.

522 F. Supp. 2d 275, 2007 U.S. Dist. LEXIS 82945, 2007 WL 3306687
Procedural entryThis page is a short order in Kaplan v. First Hartford Corp.. Read the opinion of the Court — 716 F. Supp. 2d 11
District Court, D. Maine·Decided November 7, 2007·No. Civil 05-144-B-H·Published

Opinion

FINDINGS OF FACT AND CONCLUSIONS OF LAW PART 2: REMEDY

D. BROCK HORNBY, District Judge.

The question here is remedy: What should this Maine corporation’s minority shareholder recover upon a judicial finding of oppression by a director/controlling shareholder? I conclude that the remedy is a compulsory buy-out of the minority shareholder, with his shares valued as of the day he filed his Complaint.

PROCEDURAL HlSTORY

After a bench trial, I ruled in April 2007 that a director and 43% shareholder (Ellis) of a Maine publicly held corporation (First *276 Hartford Corporation, “FHC”) had engaged in oppressive conduct with respect to a minority shareholder (Kaplan). I concluded that the minority shareholder was entitled to relief under a provision of Maine’s Business Corporation Act, 18-C M.R.S.A. § 1434. Findings of Fact and Conclusions of Law at 44 (Docket Item 81). Because the parties focused the trial on liability, I did not then determine what remedy was appropriate for the oppression. Instead, I asked for further briefing on that issue and, if necessary, additional evidence. Id. at 46. I did observe that, as of that point, minority shareholder Kaplan did not seek FHC’s outright dissolution. Id. at 44.

FHC asked me to modify my findings of fact and conclusions of law, to make explicit that neither dissolution nor appointment of an independent receiver would be an appropriate remedy. Def. FHC’s Mot. for Additional Findings at 1 (Docket Item 84). I denied that motion in May, declining to limit available alternatives at that time. Order on Def. FHC’s Mot. for Additional Findings of Fact and Conclusions of Law (Docket Item 92).

Next, the parties filed their briefs on the appropriate remedy. FHC and Ellis both asserted that FHC should buy out minority shareholder Kaplan “to the extent [FHC] has the financial capacity to do so.” Def. FHC’s Position on Remedies at 1 (Docket Item 93). FHC proposed the following sequence:

first, “an order by the Court that Plaintiff shall sell the Richard Kaplan Shares, at their fair value, to FHC”;
next, “appropriate discovery” on the subject of fair value;
then, designation of experts and depositions;
finally, a hearing on fair value.

Id. at 2. If FHC should be financially unable to buy out Kaplan, then “the Court may be required to consider other remedies which would necessitate a subsequent hearing.” Id. at 3. Kaplan mostly agreed. Kaplan asserted that a purchase by either FHC or Ellis was “the most equitable path to disentanglement.... Absent judicial intervention ordering such a buy-out, minority shareholders have no remedy.” Pl.’s Br. on Remedies at 2 (Docket Item 95). Kaplan wanted to retain the option of dissolution, but only if I determined that an FHC or Ellis buy-out was “not feasible.” Id. at 3, 12-13. Indeed, Kaplan took the position that “the Court could now [i.e., at the time of that briefing] order a buy-out at fair value, with fair value to be determined.” Id. at 19.

As a result of such statements, I concluded in June 2007 that “there is conceptual agreement on the general form of relief to be ordered (buy-out of the plaintiff Kaplan if the defendant First Hartford Corporation (‘FHC’) is financially capable).” Procedural Order of June 14, 2007 (Docket Item 99). At the lawyers’ request, I scheduled a conference of counsel. At the conference, they produced an agreed-upon scheduling order but informed me that they had not been able to agree on the date for a valuation. Instead, they proposed to undertake discovery, hoping that a practical valuation date would emerge on which they could all agree, but reserving the possibility that if they failed to agree, I would have to make a legal ruling on what was the appropriate valuation date.

Unfortunately, discovery thereafter bogged down (more accurately, it did not occur), and at a later conference of counsel they informed me that they could not agree on a valuation date at all, and that I would have to make a ruling on the correct valuation date. I therefore ordered brief *277 ing on what the valuation date should be (and also ordered discovery to go forward). Procedural Order of October 4, 2007 (Docket Item 110).

In the most recent briefing, minority shareholder Kaplan intimates that he does not really join in the request to have me choose a valuation date now, Pl.’s Br. on Valuation Date and Scope of Hr’g at 2 (Docket Item 112), and that my doing so might amount to an advisory opinion. 1 He then takes the position that the valuation date should be “the date of the decree,” id. at 1, close to when he is “cashed out of his shares.” Id. at 6-7. He also steps back from any commitment to a buy-out remedy, saying that he “reserved any argument about which remedy is most appropriate.” Id. at 1 n. 1. FHC asks for a valuation date that is either the day before the date Kaplan filed his Complaint, or the date on which I determine that oppression first existed. Def. FHC’s Mem. of Law on Valuation Date and SEC Acknowledgments at 1 (Docket Item 111). Ellis, the 43% shareholder, has not filed a brief on this issue.

I now conclude that FHC must buy Kaplan’s shares. I also conclude that the appropriate valuation date is the day Kap-lan filed his Complaint, i.e., September 15, 2005. If I am later persuaded that FHC cannot financially accomplish the purchase, then Ellis must buy the shares. If neither FHC nor Ellis can buy the shares, then I will proceed to consider dissolution. But if dissolution results in a lower payment to Kaplan, I will consider holding Ellis responsible for the difference, since Ellis controls information about FHC, the value of its real estate portfolio, and his own assets and, as I have found previously, he has regularly mingled his own assets with those of FHC. I will not permit Ellis to determine, post hoc, which date is most beneficial to him.

Analysis

When a shareholder shows that those in control of a Maine corporation have acted oppressively, judicial dissolution of the corporation is appropriate. 13-C M.R.S.A. § 1430(2)(B). However, a court may also grant different relief “that in its discretion it considers appropriate,” 13-C M.R.S.A. § 1434(2), including an order that “the corporation or ... other shareholders” “purchase at their fair value ... shares of any shareholder.” 13-C M.R.S.A. § 1434(2)(A).

I now exercise that discretion under section 1434(2) to declare that a buyout is the appropriate remedy. In my original findings of fact and conclusions of law on liability, I expressed my reluctance to order dissolution of this publicly held corporation. Findings of Fact and Conclusions of Law at 44 n. 55. All the parties agreed some months ago that buy-out is the preferred remedy, notwithstanding Kaplan’s recently cooling ardor.

Free access — add to your briefcase to read the full text and ask questions with AI

Kaplan v. First Hartford Corp., 522 F. Supp. 2d 275, 2007 U.S. Dist. LEXIS 82945, 2007 WL 3306687 (D. Me. 2007).

522 F. Supp. 2d 275 (Kaplan v. First Hartford Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Hughes v. Sego Int'l Ltd.
469 A.2d 74 (New Jersey Superior Court App Division, 1983)